SCHEMBL255876

SCHEMBL255876

O=C1C=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30923519 0.97
SCHEMBL28735200 0.97
Selenium SCHEMBL29864615 0.97
SCHEMBL3676724 0.97
Charcoal, Activated SCHEMBL29797978 0.97
Methoxymethane SCHEMBL3177988 0.89
Hydrochloric Acid SCHEMBL30279568 0.85
SCHEMBL29992751 0.83
Monoethanolamine SCHEMBL29860580 0.81 ALDH1A1 (0.35)
SCHEMBL29535833 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3487495-B1 4-(4-CHLOROPHENYL)-5-METHYLENE-PYRROL-2-ONE OR 5- METHYLENE-4-(P-TOLYL)PYRROL-2-ONE FOR USE IN THE TREATMENT OF A BACTERIAL SKIN LESIONS UNILEVER IP HOLDINGS B V (NL) 2026-04-22 EP claimed
EP-3487496-B1 4-(4-CHLOROPHENYL)-5-METHYLENE-PYRROL-2-ONE AND 5-METHYLENE-4-(P-TOLYL)PYRROL-2-ONE FOR USE IN THE TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTIONS UNILEVER IP HOLDINGS B V (NL) 2026-04-08 EP claimed
EP-3487494-B1 4-(4-CHLOROPHENYL)-5-METHYLENE-PYRROL-2-ONE OR 5-METHYLENE-4-(P-TOLYL)PYRROL-2-ONE FOR USE IN THE TREATMENT OF BACTERIAL RESPIRATORY TRACT INFECTION UNILEVER IP HOLDINGS B V (NL) 2026-03-25 EP claimed
US-20250354873-A1 TEMPERATURE INTEGRITY SENSOR UNIVERSITÀ DEGLI STUDI DI CAGLIARI (IT) 2025-11-20 US claimed
CN-120019103-A Sulfur-triazine polymer and lithium-sulfur battery comprising same as positive electrode and capable of being used in lean electrolyte 庆尚国立大学产合合作团 2025-05-16 CN claimed
CN-119956084-A Composite extraction system and process for extracting lithium from lithium-containing solution 中国科学院过程工程研究所 2025-05-09 CN claimed
CN-119899941-A Lithium composite extractant and method for extracting lithium 中国科学院过程工程研究所 2025-04-29 CN claimed
CN-119874762-A Novel tracer11Precursor structural design of C-UCB-J and preparation method thereof 江苏华益科技有限公司 2025-04-25 CN claimed
EP-4540586-A2 TEMPERATURE INTEGRITY SENSOR Università Degli Studi di Cagliari (IT) 2025-04-23 EP claimed
CN-118299594-B Tripyrrole-N precisely coordinated monoatomic material, preparation method thereof and application thereof in fuel cell 天津大学 2025-02-11 CN claimed
EP-0885227-A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1998-12-23 EP claimed
WO-1997032882-A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
EP-0714391-A1 SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1996-06-05 EP claimed
WO-1995005376-A1 SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1995-02-23 WO claimed
EP-0409163-B1 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors MERRELL DOW PHARMA (US) 1994-12-21 EP claimed
US-5332833-A Potassium channel modulator, hypotensive, hypersensitive colon syndrome, asthma, enteritis MITSUBISHI KASEI CORPORATION (JP) 1994-07-26 US claimed
WO-1994002434-A1 EXPLOSIVE BODY FÖRSVARETS FORSKNINGSANSTALT (SE) 1994-02-03 WO claimed
EP-0409163-A2 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-23 EP claimed
EP-0367888-A1 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1990-05-16 EP claimed
CN-1040582-A New peptidase inhibitors MERRELL DOW PHARMA (US) 1990-03-21 CN claimed